1. Home
  2. AYTU vs JYD Comparison

AYTU vs JYD Comparison

Compare AYTU & JYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • JYD
  • Stock Information
  • Founded
  • AYTU N/A
  • JYD 2001
  • Country
  • AYTU United States
  • JYD China
  • Employees
  • AYTU N/A
  • JYD N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • JYD Oil Refining/Marketing
  • Sector
  • AYTU Health Care
  • JYD Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • JYD Nasdaq
  • Market Cap
  • AYTU 19.7M
  • JYD 18.9M
  • IPO Year
  • AYTU N/A
  • JYD 2023
  • Fundamental
  • Price
  • AYTU $2.37
  • JYD $0.14
  • Analyst Decision
  • AYTU Strong Buy
  • JYD
  • Analyst Count
  • AYTU 2
  • JYD 0
  • Target Price
  • AYTU $10.00
  • JYD N/A
  • AVG Volume (30 Days)
  • AYTU 100.5K
  • JYD 959.4K
  • Earning Date
  • AYTU 11-12-2025
  • JYD 10-24-2025
  • Dividend Yield
  • AYTU N/A
  • JYD N/A
  • EPS Growth
  • AYTU N/A
  • JYD N/A
  • EPS
  • AYTU N/A
  • JYD N/A
  • Revenue
  • AYTU $81,659,000.00
  • JYD $77,444,271.00
  • Revenue This Year
  • AYTU N/A
  • JYD N/A
  • Revenue Next Year
  • AYTU $2.00
  • JYD N/A
  • P/E Ratio
  • AYTU N/A
  • JYD N/A
  • Revenue Growth
  • AYTU 0.41
  • JYD 13.54
  • 52 Week Low
  • AYTU $0.95
  • JYD $0.09
  • 52 Week High
  • AYTU $2.85
  • JYD $8.00
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 55.75
  • JYD 35.42
  • Support Level
  • AYTU $2.21
  • JYD $0.13
  • Resistance Level
  • AYTU $2.58
  • JYD $0.16
  • Average True Range (ATR)
  • AYTU 0.13
  • JYD 0.01
  • MACD
  • AYTU 0.01
  • JYD -0.00
  • Stochastic Oscillator
  • AYTU 48.78
  • JYD 28.07

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About JYD Jayud Global Logistics Limited

Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, supply chain management, and other value-added services.

Share on Social Networks: